New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
06:44 EDTPBYIPuma Biotechnology price target raised to $27 from $20 at Leerink
Leerink raised its price target for Puma Biotechnology citing the company's progress in advancing neratinib. The firm keeps an Outperform rating on the stock.
News For PBYI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
07:15 EDTPBYIFDA to hold workshop on breast cancer drug development
Subscribe for More Information
October 16, 2014
09:21 EDTPBYIPuma Biotechnology participates in a conference call hosted by UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use